Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

606 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial.
Nilsson M, Olafsdottir H, Alexandersson von Döbeln G, Villegas F, Gagliardi G, Hellström M, Wang QL, Johansson H, Gebski V, Hedberg J, Klevebro F, Markar S, Smyth E, Lagergren P, Al-Haidari G, Rekstad LC, Aahlin EK, Wallner B, Edholm D, Johansson J, Szabo E, Reynolds JV, Pramesh CS, Mummudi N, Joshi A, Ferri L, Wong RK, O'Callaghan C, Lukovic J, Chan KK, Leong T, Barbour A, Smithers M, Li Y, Kang X, Kong FM, Chao YK, Crosby T, Bruns C, van Laarhoven H, van Berge Henegouwen M, van Hillegersberg R, Rosati R, Piessen G, de Manzoni G, Lordick F. Nilsson M, et al. Among authors: van hillegersberg r, van berge henegouwen m, van laarhoven h. Front Oncol. 2022 Jul 13;12:917961. doi: 10.3389/fonc.2022.917961. eCollection 2022. Front Oncol. 2022. PMID: 35912196 Free PMC article.
Biodegradable stent placement before neoadjuvant chemoradiotherapy as a bridge to surgery in patients with locally advanced esophageal cancer.
van den Berg MW, Walter D, de Vries EM, Vleggaar FP, van Berge Henegouwen MI, van Hillegersberg R, Siersema PD, Fockens P, van Hooft JE. van den Berg MW, et al. Among authors: van hooft je, van hillegersberg r, van berge henegouwen mi. Gastrointest Endosc. 2014 Nov;80(5):908-13. doi: 10.1016/j.gie.2014.06.004. Epub 2014 Jul 26. Gastrointest Endosc. 2014. PMID: 25070907 No abstract available.
Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol.
Noordman BJ, Shapiro J, Spaander MC, Krishnadath KK, van Laarhoven HW, van Berge Henegouwen MI, Nieuwenhuijzen GA, van Hillegersberg R, Sosef MN, Steyerberg EW, Wijnhoven BP, van Lanschot JJ; SANO study group. Noordman BJ, et al. Among authors: van lanschot jj, van laarhoven hw, van hillegersberg r, van berge henegouwen mi. JMIR Res Protoc. 2015 Jun 29;4(2):e79. doi: 10.2196/resprot.4320. JMIR Res Protoc. 2015. PMID: 26121676 Free PMC article.
Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival.
Goense L, van der Sluis PC, van Rossum PSN, van der Horst S, Meijer GJ, Haj Mohammad N, van Vulpen M, Mook S, Ruurda JP, van Hillegersberg R. Goense L, et al. Among authors: van der sluis pc, van hillegersberg r, van der horst s, van vulpen m, van rossum psn. J Surg Oncol. 2017 Jun;115(7):812-820. doi: 10.1002/jso.24596. Epub 2017 Mar 7. J Surg Oncol. 2017. PMID: 28267212
Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma.
Anderegg MCJ, van der Sluis PC, Ruurda JP, Gisbertz SS, Hulshof MCCM, van Vulpen M, Mohammed NH, van Laarhoven HWM, Wiezer MJ, Los M, van Berge Henegouwen MI, van Hillegersberg R. Anderegg MCJ, et al. Among authors: van der sluis pc, van hillegersberg r, van laarhoven hwm, van vulpen m, van berge henegouwen mi. Ann Surg Oncol. 2017 Aug;24(8):2282-2290. doi: 10.1245/s10434-017-5827-1. Epub 2017 Apr 19. Ann Surg Oncol. 2017. PMID: 28424936 Free PMC article.
Postoperative Outcomes of Minimally Invasive Gastrectomy Versus Open Gastrectomy During the Early Introduction of Minimally Invasive Gastrectomy in the Netherlands: A Population-based Cohort Study.
Brenkman HJF, Gisbertz SS, Slaman AE, Goense L, Ruurda JP, van Berge Henegouwen MI, van Hillegersberg R; Dutch Upper Gastrointestinal Cancer Audit (DUCA) group. Brenkman HJF, et al. Among authors: van hillegersberg r, van berge henegouwen mi. Ann Surg. 2017 Nov;266(5):831-838. doi: 10.1097/SLA.0000000000002391. Ann Surg. 2017. PMID: 28742708
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.
Noordman BJ, Spaander MCW, Valkema R, Wijnhoven BPL, van Berge Henegouwen MI, Shapiro J, Biermann K, van der Gaast A, van Hillegersberg R, Hulshof MCCM, Krishnadath KK, Lagarde SM, Nieuwenhuijzen GAP, Oostenbrug LE, Siersema PD, Schoon EJ, Sosef MN, Steyerberg EW, van Lanschot JJB; SANO study group. Noordman BJ, et al. Among authors: van hillegersberg r, van berge henegouwen mi, van der gaast a, van lanschot jjb. Lancet Oncol. 2018 Jul;19(7):965-974. doi: 10.1016/S1470-2045(18)30201-8. Epub 2018 Jun 1. Lancet Oncol. 2018. PMID: 29861116
606 results